Hematological Toxicity During Concomitant Treatment With Ruxolitinib and Avelumab for Merkel Cell Carcinoma

Overview of attention for article published in Frontiers in oncology, October 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination

Article in Frontiers in Oncology (June 2023)

Progress of the pathogenesis in Merkel cell carcinoma

Article in Cancer Research and Clinic (September 2022)

Cutaneous Merkel cell carcinoma (MCC): A report from the 16th Annual Meeting for Multicenter Merkel Interest Group – A supplementation to the new European guidelines 2022 on MCC

Article in European Journal of Cancer (September 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.